CME (CME Group) Moat Score: 8/10 (As of Jun. 28, 2026)


CME CME Group Inc CME
92 GF Score
Price $221.00
GF Value $270.96
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is CME Group Moat Score?

CME Group CME -1.78% 92 Moat Score is 8 as of Jun. 28, 2026. GuruFocus rates CME with a GF Score™ of 92/100 and a GF Value™ of $270.96 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 841 Capital Markets companies, CME Group ranks better than 99.88% on this metric.

CME Group has the Moat Score of 8, which implies that the company might have Wide Moat - Clear and robust wide moat.

CME Group has Wide Moat: CME Group has a robust wide moat due to its dominant market position in derivatives trading, significant network effects, and high customer switching costs. Its regulatory barriers and strong brand further enhance its competitive advantage.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes CME Group might have Wide Moat - Clear and robust wide moat.

CME Group  (NAS:CME) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

CME Group Moat Score Related Terms

CME vs ICE, MCO, SPGI: Moat Score Comparison

For the Financial Data & Stock Exchanges subindustry, CME Group's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CME Group Moat Score vs Capital Markets Industry

For the Capital Markets industry and Financial Services sector, CME Group's Moat Score distribution charts can be found below:

* The bar in red indicates where CME Group's Moat Score falls into.


CME
92GF Score
CME Group Inc CME
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 8 mean?
CME Group (CME) has a Moat Score of 8 as of Jun. 28, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, CME Group ranks #1 out of 841 companies in the Capital Markets industry, placing it in the top 0.099999999999994%.
Is CME Group's Moat Score too high?
CME Group's current Moat Score is 8. Based on the distribution chart, CME Group ranks #1 out of 841 companies in the Capital Markets industry, which is in the top quartile — a strong position relative to peers. Overall, CME Group has a GF Score™ of 92/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does CME Group's Moat Score compare to ICE and MCO?
According to the Capital Markets industry distribution chart, CME Group ranks #1 out of 841 companies for Moat Score. This places CME Group in the top 0% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Capital Markets company?
A good Moat Score depends on the Capital Markets industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. CME Group's current Moat Score is 8. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CME Group stock overvalued right now?
Based on GuruFocus' analysis, CME Group (CME) is currently considered Modestly Undervalued. The stock's GF Value™ is $270.96, compared to a current price of $221.00 — trading 18.4% below its estimated fair value. The current Moat Score is 8. CME Group's overall GF Score™ is 92/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For CME Group (CME), the current Moat Score is 8 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CME Group (CME) Overvalued in 2026?

Based on GuruFocus' analysis, CME Group stock appears to be undervalued. The current stock price of $221.00 is trading 18.4% below its estimated GF Value™ of $270.96. GuruFocus considers CME Group to be Modestly Undervalued.

Key valuation signals for CME:

  • Moat Score: 8
  • GF Value™: $270.96 vs. price of $221.00 (18.4% below fair value)
  • GF Score™: 92/100 with 4 warning signs

No single metric tells the full story. See the CME stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

CME Group Business Description

Address 20 South Wacker Drive, Chicago, IL, USA, 60606
Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P Dow Jones Indexes, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.
92GF Score

Get the complete analysis for CME

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$221.00
Price
$270.96
GF Value